ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Insulin-Like Growth Factor Inhibition In Lung Cancer"
Episode Synopsis
Oncology Times Broadcast News with the Audio Journal of Oncology
Reporting from: 10th European Congress Perspectives in Lung Cancer, Brussels March 6-7, 2009 and Journal of Clinical Oncology
Insulin-Like Growth Factor Inhibition In Lung Cancer
Silvia Novello, and Giorgio Scagliotti from the University of Turin about harnessing insulin-like growth factor receptor inhibition in a phase II study which has shown clinical activity of figitumomab at least as significant as inhibitors of other growth factors already being used in cancer.
Reporting from: 10th European Congress Perspectives in Lung Cancer, Brussels March 6-7, 2009 and Journal of Clinical Oncology
Insulin-Like Growth Factor Inhibition In Lung Cancer
Silvia Novello, and Giorgio Scagliotti from the University of Turin about harnessing insulin-like growth factor receptor inhibition in a phase II study which has shown clinical activity of figitumomab at least as significant as inhibitors of other growth factors already being used in cancer.
More episodes of the podcast Oncology Times Broadcast News
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer
28/09/2009
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos
28/09/2009
In God we trust